![Angus J. Grant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Angus J. Grant
Président chez
Toronto Innovation Acceleration Partners
Profil
Dr. Angus J.
Grant is a Chairman at Toronto Innovation Acceleration Partners.
Dr. Grant was previously employed as an Executive Vice President-Business Development by Teva Pharmaceutical Industries Ltd., a Chief Business Executive by BeiGene Ltd., and a Chief Executive Officer by SV Health Investors LLP.
He also served on the board at Caraway Therapeutics, Inc., Cerevance, Inc. and Tiaki Therapeutics, Inc. He received his undergraduate degree from the University of Richmond and a doctorate degree from Medical College of Virginia.
Postes actifs de Angus J. Grant
| Sociétés | Poste | Début |
|---|---|---|
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Operates as a commercialization agent | Président | - |
Anciens postes connus de Angus J. Grant
| Sociétés | Poste | Fin |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2025 |
| BEIGENE LTD | Corporate Officer/Principal | - |
Tiaki Therapeutics, Inc.
 Tiaki Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics for Alzheimer's disease | Directeur/Membre du Conseil | - |
Caraway Therapeutics, Inc.
 Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases | Directeur/Membre du Conseil | - |
Cerevance, Inc.
 Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Directeur/Membre du Conseil | - |
Formation de Angus J. Grant
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
University of Richmond
 University of Richmond Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
 Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Operates as a commercialization agent | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Cerevance, Inc.
Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Caraway Therapeutics, Inc.
Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases | Health Technology |
Tiaki Therapeutics, Inc.
Tiaki Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics for Alzheimer's disease | Commercial Services |
